NCT07316686 2026-01-05
Lutécio
Instituto do Cancer do Estado de São Paulo
Phase 1 Not yet recruiting
Instituto do Cancer do Estado de São Paulo
InSilico Medicine Hong Kong Limited
Qilu Pharmaceutical (Hainan) Co., Ltd.
Jiangsu Alphamab Biopharmaceuticals Co., Ltd